Sunvozertinib Wins Approval for EGFR-Mutated NSCLC ...Middle East

Medscape - News
Sunvozertinib Wins Approval for EGFR-Mutated NSCLC
With the approval, patients with EGFR exon 20 insertion mutations now have a once-a-day, oral option. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Sunvozertinib Wins Approval for EGFR-Mutated NSCLC )

Apple Storegoogle play

Also on site :



Latest News